Bayer's Pharma Beat Wins Two Fresh Bull Calls, but the Margin Is Only Half the Story
ASML's Slide Is a Sector Story, Not a Company Warning
Deutz Insiders Put Money Behind the Story While an Analyst Backs the Outlook
Moderna's Pipeline Wins Are Piling Up — But the November 6 Balance Sheet Is the Real Verdict
Vonovia's Disposal Engine Becomes the Real Gauge of Its Balance-Sheet Repair
Novo Nordisk's Oral Wegovy Clears Its First Hurdle — Now Comes the Price Test
BioNTech's Raised Guidance Draws the Eye, but the Pipeline Still Has to Earn the Re-rating
Silver's 4% Rebound Masks a Deeper Debate: UBS Sees $70, China's Solar Sector Says Otherwise
Lenzing's Shareholder Register Is Clear — Its Earnings Picture Is Anything But
Gold's Dollar-Driven Bounce Masks a Two-Speed Buyer Base
Rheinmetall Cuts 2026 Guidance as Artillery Deliveries Slip Into Next Year
Evonik's 40% Earnings Surge Draws Two Hold Ratings and Only One Higher Target
SpaceX's Long Road to Cash: A Qualcomm Deal, a 2031 Milestone and the Politics in Between
Take-Two's 8.4% Jump Has No Confirmed Trigger — But Two Bank Notes and a Vanguard Filing Do
Ocugen's Q3 Beat, a Provisional Bahamas Nod and a Runway to 2028
Kioxia's Sold-Out 2027 Output Collides With a Market Already Betting on a Downturn
Xiaomi's Robot Clock-In and Daiwa's Target Hike Leave the Revenue Question Unanswered
OHB Wins EUR 554 Million ESA Contract for Next-Generation Topography Satellites
Infineon's Industrial Build-Out Meets the AI Revenue Question
SNP SE Raises Outlook for the Full Year 2026
ASML Hands Out Its Dividend While the Market Argues Over AI's Payback
Nebius Stock: Washington's Chill Meets a $3.5 Billion Credit Line
Almonty's Sangdong Restart Meets a Cautious Analyst Scorecard
Deutsche Telekom's Value-Over-Volume Bet Meets Its First Real Audit on November 5
Nvidia's Regulatory Crosswinds: DOJ Scrutiny, Election Jitters and a November 17 Reckoning
Siemens Energy: AI Jitters, a 100 € Sell Call and the 11 November Verdict
Vanguard's All-World ETF Steadies Near €170 as Traders Bet on Divided Washington
Novo Nordisk's 6.4% Rebound Faces a Two-Front Audit: Brazil's Generics and America's Price Cuts
WIG 20 closes at 4,190.08 points, up 1.24%
KOSPI closes 0.62% higher at 5,683.80 after volatile US election session
FTSE 100 closes 1.86% higher at 10,836.67 after US midterm sweep
BASF's Buyback Ticks Along as Analysts Keep Their Powder Dry